Historical development and future promise of the nitrosoureas as anticancer agents.

Historical development and future promise of the nitrosoureas as anticancer agents. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Historical development and future promise of the nitrosoureas as anticancer agents. Abstract Text:

Historical development and future promise of the nitrosoureas as anticancer agents. Publishing Authors By Initials

For similar organic chemicals: nitroso compounds: nitrosourea compounds research abstracts see: organic chemicals: nitroso compounds: nitrosourea compounds research

PUBMED ID PMID:

MEDLINE DATE:

Historical development and future promise of the nitrosoureas as anticancer agents. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 3

VOLUME: 4

Page Numbers: 3-6

Journal Abbreviation:

ISSN: 0069-0139

DAY: 26

MONTH: May

YEAR: 1973

Historical development and future promise of the nitrosoureas as anticancer agents. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7609154

Historical development and future promise of the nitrosoureas as anticancer agents. Keywords Mesh Terms:

KEYWORDS: Nitrosourea Compounds

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Historical development and future promise of the nitrosoureas as anticancer agents. Information

Substance Name: Nitrosourea Compounds

Registry Number: 0

Grant and Affiliation Information for Historical development and future promise of the nitrosoureas as anticancer agents.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep 3

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Historical development and future promise of the nitrosoureas as anticancer agents Related Publications

• "Compression paddle gallstone": artifact of standard radiographic accessory.
• Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).
• Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy.
• CT evaluation of thickened esophageal walls.
• Concepts for treatment of micrometastases developed in murine systems.
• Development of Friend leukemia virus in spleen and plasma of Swiss mice.
• Ectopic cranium: postoperative abdominal wall skull fragments.
• Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells.
• Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms.
• Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine.
• Experimental evaluation of purine antagonists as anticancer agents.
• Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
• Growth requirements and biologic characteristics of leukemia L1210 cells in culture.
• Historical development and future promise of the nitrosoureas as anticancer agents.
• Laboratory study of the epidemiology of poliomyelitis.
• Rationale for perioperative anticancer treatment.
• Recovery of poliomyelitis virus from the throat during the incubation period.
• Screening, the cornerstone of chemotherapy.
• Some observations on the carcinostatic activity of Eponate on Fortner hamster plasmacytoma.
• Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
• Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
• The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.